The American Hospital Association disputed UHG’s findings, saying that drug manufacturers themselves are the main culprit in rising costs.

At a time when drug costs are a top concern for employers, UnitedHealth Group (UHG) has released a report finding that specialty drugs are a key driver of health care costs. The UHG study suggests that hospital delivery of these drugs contribute to the problem; the report claims that $4 billion could be saved if such drugs were administered outside of hospital settings.

However, the American Hospital Association (AHA) has pushed back hard, questioning the methodology of the UHG study and noting that some specialty drugs can only be administered at a hospital.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.